Curative Biotechnology Inc

Research Curative Biotechnology Inc (CUBT) on Bullrun: market cap USD 9.19M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCUBT
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 9.19M
• Financial periodQ1 2023
• Net income-USD 5.17M
• Free cash flow-USD 534.89K

Valuation Snapshot

latest market cap is USD 9.19M.

About Curative Biotechnology Inc

Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies;

Frequently asked questions

What is Curative Biotechnology Inc's market cap?

Curative Biotechnology Inc's market capitalization is USD 9.19M.

What does Curative Biotechnology Inc do?

Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy;